ArticleThe journal of liquid biopsy2026
Tissue expression of miR-504-5p and miR-429 as diagnostic biomarkers for endometrial cancer and endometrial intraepithelial neoplasia: a pilot study.
Article in The journal of liquid biopsy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Endometrial cancer (EC) is the sixth most frequent female malignancy worldwide. Atypical endometrial hyperplasia (AEH), also termed endometrial intraepithelial neoplasia (EIN), represents the recognized precursor lesion. While hysteroscopy with biopsy remains the diagnostic gold standard, the lack of non-invasive biomarkers for early detection and follow-up is a major clinical limitation. MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, have emerged as potential diagnostic and prognostic tools in gynecological oncology. Objective: We aimed to determine the accuracy of the predictive value of a selected panel of miRNAs (miR-504-5p and miR-429) obtained on endometrial samples, in detecting EC and EIN, and to explore their role along the neoplastic continuum. Methods: A prospective observational study was conducted at the University of Naples "Federico II." Thirty-seven patients were enrolled: EC (n = 15), EIN (n = 15), and controls with normal endometrium (n = 7). All underwent hysteroscopy with grasp biopsy or "Visual D&C." Formalin-fixed paraffin-embedded samples were processed for RNA extraction, and miRNA expression was analyzed by RT-PCR (Taqman Advanced miRNA Assays). Results: Both miRNAs were successfully amplified in most cases. In EC, miR-504-5p was detected in 93.3 % and miR-429 in 100 % of samples, with mean Ct values of 32.2 and 29.7, respectively. AEH showed intermediate expression (93.3 % and 86.7 % detection rates; mean Ct 28.3 and 29.8). Normal endometrium displayed the highest expression (100 % and 85.7 %; mean Ct 25.5 and 26.8). A progressive downregulation of both miRNAs from normal tissue to AEH and EC was observed. Conclusion: Our preliminary findings suggest that reduced expression of miR-504-5p and miR-429 characterizes the transition from EIN to EC, supporting their potential role as tumor suppressors in this setting. This two-miRNA panel could complement histopathology in distinguishing precursor lesions from carcinoma, addressing a key diagnostic challenge. Larger studies, including minimally invasive liquid biopsy approaches, are warranted to validate their clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.